Several signaling pathways were found to be regulated by LRRN4, including the Ras signaling pathway and the mitogen-activated protein kinase (MAPK) and phosphoinositide-3 kinase (PI3K) pathways, which are known to correlate with the malignant phenotype of cancer cells [27–31]. This evidence concerns the gene LRRN4 and cancer.